A Novel Peptide Drug Conjugate Targeting the Scavenger Receptor Sortilin 1 That Exhibits Potent In Vivo Efficacy in Triple Negative Breast Cancer Tumour Models
Time: 9:15 am
day: Conference Day 2
Details:
- Explore the intricacies of peptide design tailored for optimal affinity to a specific antigen, ensuring precise targeting for therapeutic delivery
- Investigate the mechanism of receptor-mediated internalisation, wherein peptide-bound receptors facilitate the uptake of chemotherapeutic payloads into target cells, enhancing therapeutic efficacy
- Discover the transformative potential of peptide-conjugated chemotherapeutic agents in unlocking targeted therapies, offering new avenues for personalised treatment strategies in oncology and beyond
